ReP USP - Resultado da busca

Artigo de periodico
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes (2020)
Ramin-mangata, Stephane; Wargny, Matthieu; Pichelin, Matthieu; May, Cedric Le; Thedrez, Aurelie; Blanchard, Valentin; Nativel, Brice; Santos, Raul D; Bensenor, Isabela Judith Martins ; Lotufo, Paulo Andrade
Source: Atherosclerosis. Unidade: FM
Subjects: LIPOPROTEÍNAS LDL, ENZIMAS PROTEOLÍTICAS, DIABETES MELLITUS NÃO INSULINO-DEPENDENTE, HOMEOSTASE, GLICOSE, FATORES DE RISCO, ELISA, ESTUDOS LONGITUDINAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMIN-MANGATA, Stephane; WARGNY, Matthieu; PICHELIN, Matthieu; et al. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis, Clare, v. 293, p. 49-56, 2020. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/35376 > DOI: 10.1016/j.atherosclerosis.2019.11.027.
APA
Ramin-mangata, S., Wargny, M., Pichelin, M., May, C. L., Thedrez, A., Blanchard, V., et al. (2020). Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes. Atherosclerosis, 293, 49-56. doi:10.1016/j.atherosclerosis.2019.11.027
NLM
Ramin-mangata S, Wargny M, Pichelin M, May CL, Thedrez A, Blanchard V, Nativel B, Santos RD, Bensenor IJM, Lotufo PA. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes [Internet]. Atherosclerosis. 2020 ; 293 49-56.Available from: http://observatorio.fm.usp.br/handle/OPI/35376
Vancouver
Ramin-mangata S, Wargny M, Pichelin M, May CL, Thedrez A, Blanchard V, Nativel B, Santos RD, Bensenor IJM, Lotufo PA. Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes [Internet]. Atherosclerosis. 2020 ; 293 49-56.Available from: http://observatorio.fm.usp.br/handle/OPI/35376
Artigo de periodico-carta/editorial
Very high LDL cholesterol: the power of zero passes another test [Editorial] (2020)
Bittencourt, Márcio Sommer; Nasir, Khurram; Santos, Raul D; Al-Mallah, Mouaz H
Source: Atherosclerosis. Unidade: HU
Subjects: HIPERLIPIDEMIA, CÁLCIO, FATORES DE RISCO, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITTENCOURT, Márcio Sommer; NASIR, Khurram; SANTOS, Raul D; AL-MALLAH, Mouaz H. Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis[S.l: s.n.], 2020. DOI: 10.1016/j.atherosclerosis.2019.11.019.
APA
Bittencourt, M. S., Nasir, K., Santos, R. D., & Al-Mallah, M. H. (2020). Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. Amsterdam: International Atherosclerosis Society. doi:10.1016/j.atherosclerosis.2019.11.019
NLM
Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH. Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. 2020 ; 292 207-208.
Vancouver
Bittencourt MS, Nasir K, Santos RD, Al-Mallah MH. Very high LDL cholesterol: the power of zero passes another test [Editorial]. Atherosclerosis. 2020 ; 292 207-208.
Artigo de periodico-carta/editorial
Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? (2020)
Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: ARTERIOSCLEROSE, CALCIFICAÇÃO FISIOLÓGICA, VASOS CORONÁRIOS, CORONARIOPATIA, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? Atherosclerosis[S.l: s.n.], 2020.Disponível em: DOI: 10.1016/j.atherosclerosis.2019.12.019.
APA
Santos Filho, R. D. dos. (2020). Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? Atherosclerosis. Clare. doi:10.1016/j.atherosclerosis.2019.12.019
NLM
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.Available from: http://observatorio.fm.usp.br/handle/OPI/35425
Vancouver
Santos Filho RD dos. Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels? [Internet]. Atherosclerosis. 2020 ; 294 44-45.Available from: http://observatorio.fm.usp.br/handle/OPI/35425
Artigo de periodico
Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia (2019)
Reeskamp, Laurens F; Kastelein, John J. P; Moriarty, Patrick M; Duell, P. Barton; Catapano, Alberico L; Santos Filho, Raul Dias dos; Ballantyne, Christie M
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, OLIGONUCLEOTÍDEOS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REESKAMP, Laurens F; KASTELEIN, John J. P; MORIARTY, Patrick M; et al. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, Clare, v. 280, p. 109-117, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/30821 > DOI: 10.1016/j.atherosclerosis.2018.11.017.
APA
Reeskamp, L. F., Kastelein, J. J. P., Moriarty, P. M., Duell, P. B., Catapano, A. L., Santos Filho, R. D. dos, & Ballantyne, C. M. (2019). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 280, 109-117. doi:10.1016/j.atherosclerosis.2018.11.017
NLM
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.Available from: http://observatorio.fm.usp.br/handle/OPI/30821
Vancouver
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.Available from: http://observatorio.fm.usp.br/handle/OPI/30821
Artigo de periodico
Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil (2019)
Harada, Paulo H; Benseñor, Isabela M; Drager, Luciano F; Goulart, Alessandra Carvalho; Mill, José G; Lotufo, Paulo Andrade
Source: Atherosclerosis. Unidades: FM, HU
Subjects: FÍGADO GORDUROSO, AORTA, DOENÇAS CARDIOVASCULARES, OBESIDADE, GRUPOS ÉTNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HARADA, Paulo H; BENSEÑOR, Isabela M; DRAGER, Luciano F; et al. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil. Atherosclerosis, Amsterdam, Elsevier, v. 284, p. 59-65, 2019. Disponível em: < https://www.sciencedirect.com/science/article/pii/S0021915019300838?via%3Dihub > DOI: 10.1016/j.atherosclerosis.2019.02.005.
APA
Harada, P. H., Benseñor, I. M., Drager, L. F., Goulart, A. C., Mill, J. G., & Lotufo, P. A. (2019). Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil. Atherosclerosis, 284, 59-65. doi:10.1016/j.atherosclerosis.2019.02.005
NLM
Harada PH, Benseñor IM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil [Internet]. Atherosclerosis. 2019 ; 284 59-65.Available from: https://www.sciencedirect.com/science/article/pii/S0021915019300838?via%3Dihub
Vancouver
Harada PH, Benseñor IM, Drager LF, Goulart AC, Mill JG, Lotufo PA. Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: the ELSA-Brasil [Internet]. Atherosclerosis. 2019 ; 284 59-65.Available from: https://www.sciencedirect.com/science/article/pii/S0021915019300838?via%3Dihub
Trabalho de evento-resumo periodico
Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle (2019)
Pinto, Paula Ramos ; Bianco, Vanessa Del; Bochi, Ana Paula Garcia; Ferreira, Guilherme da Silva; Trevisani, M. da Silva; Rodrigues, L. Gomes; Nakandakare, Edna Regina; Okamoto, Maristela Mitiko; Machado, Ubiratan Fabres ; Catanozi, Sergio ; Passarelli, Marisa
Source: Atherosclerosis. Conference titles: 87th European Atherosclerosis Society (EAS) Congress. Maastricht, Países Baixos. Unidades: FM, ICB
Subjects: FISIOLOGIA, RESISTÊNCIA À INSULINA, EXERCÍCIO FÍSICO, TREINAMENTO AERÓBIO, TREINAMENTO FÍSICO, SÓDIO, MÚSCULO ESQUELÉTICO, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Paula Ramos; BIANCO, Vanessa Del; BOCHI, Ana Paula Garcia; et al. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle. Atherosclerosis[S.l: s.n.], 2019.Disponível em: DOI: 10.1016/j.atherosclerosis.2019.06.273.
APA
Pinto, P. R., Bianco, V. D., Bochi, A. P. G., Ferreira, G. da S., Trevisani, M. da S., Rodrigues, L. G., et al. (2019). Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle. Atherosclerosis. Amsterdan: Elsevier. doi:10.1016/j.atherosclerosis.2019.06.273
NLM
Pinto PR, Bianco VD, Bochi APG, Ferreira G da S, Trevisani M da S, Rodrigues LG, Nakandakare ER, Okamoto MM, Machado UF, Catanozi S, Passarelli M. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle [Internet]. Atherosclerosis. 2019 ; 287 e94.Available from: https://doi.org/10.1016/j.atherosclerosis.2019.06.273
Vancouver
Pinto PR, Bianco VD, Bochi APG, Ferreira G da S, Trevisani M da S, Rodrigues LG, Nakandakare ER, Okamoto MM, Machado UF, Catanozi S, Passarelli M. Aerobic exercise training counteracts insulin resistance induced by low sodium diet by increasing insulin signaling in muscle [Internet]. Atherosclerosis. 2019 ; 287 e94.Available from: https://doi.org/10.1016/j.atherosclerosis.2019.06.273
Artigo de periodico
In memoriam: Dr. Akira Yamamoto 1932-2019 (2019)
Matsuzawa, Yuji; Yamashita, Shizuya; Santos Filho, Raul Dias dos; Libby, Peter
Source: Atherosclerosis. Unidade: FM
Subjects: ESTATINAS, BIOGRAFIAS, MEDICINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATSUZAWA, Yuji; YAMASHITA, Shizuya; SANTOS FILHO, Raul Dias dos; LIBBY, Peter. In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, Clare, v. 283, p. 120-120, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/31641 > DOI: 10.1016/j.atherosclerosis.2019.01.028.
APA
Matsuzawa, Y., Yamashita, S., Santos Filho, R. D. dos, & Libby, P. (2019). In memoriam: Dr. Akira Yamamoto 1932-2019. Atherosclerosis, 283, 120-120. doi:10.1016/j.atherosclerosis.2019.01.028
NLM
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.Available from: http://observatorio.fm.usp.br/handle/OPI/31641
Vancouver
Matsuzawa Y, Yamashita S, Santos Filho RD dos, Libby P. In memoriam: Dr. Akira Yamamoto 1932-2019 [Internet]. Atherosclerosis. 2019 ; 283 120-120.Available from: http://observatorio.fm.usp.br/handle/OPI/31641
Artigo de periodico
Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps (2019)
Santos Filho, Raul Dias dos; Valenti, Luca; Romeo, Stefano
Source: Atherosclerosis. Unidade: FM
Subjects: FÍGADO GORDUROSO, HEPATOPATIAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos; VALENTI, Luca; ROMEO, Stefano. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, Clare, v. 282, p. 110-120, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/31119 > DOI: 10.1016/j.atherosclerosis.2019.01.029.
APA
Santos Filho, R. D. dos, Valenti, L., & Romeo, S. (2019). Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. Atherosclerosis, 282, 110-120. doi:10.1016/j.atherosclerosis.2019.01.029
NLM
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.Available from: http://observatorio.fm.usp.br/handle/OPI/31119
Vancouver
Santos Filho RD dos, Valenti L, Romeo S. Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps [Internet]. Atherosclerosis. 2019 ; 282 110-120.Available from: http://observatorio.fm.usp.br/handle/OPI/31119
Artigo de periodico
Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users (2019)
Souza, Francis Ribeiro de; Santos, Marcelo Rodrigues dos; Porello, Rafael Armani; Fonseca, Guilherme Wesley Peixoto da; Sayegh, Ana Luiza Carrari; Lima, Thaís Pinheiro; Ferreira, Fabiana Dias; Oliveira, Tiago Franco de; Yonamine, Maurício ; Takayama, Liliam; Pereira, Rosa Maria Rodrigues; Negrão, Carlos Eduardo; Passarelli, Marisa; Rochitte, Carlos Eduardo; Alves, Maria Janieire de Nazaré Nunes
Source: Atherosclerosis. Unidades: FCF, FM, EEFE
Subjects: COLESTEROL, DOENÇAS CARDIOVASCULARES, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Francis Ribeiro de; SANTOS, Marcelo Rodrigues dos; PORELLO, Rafael Armani; et al. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis, Clare, v. 283, p. 100-105, 2019. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2019.02.006 > DOI: 10.1016/j.atherosclerosis.2019.02.006.
APA
Souza, F. R. de, Santos, M. R. dos, Porello, R. A., Fonseca, G. W. P. da, Sayegh, A. L. C., Lima, T. P., et al. (2019). Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users. Atherosclerosis, 283, 100-105. doi:10.1016/j.atherosclerosis.2019.02.006
NLM
Souza FR de, Santos MR dos, Porello RA, Fonseca GWP da, Sayegh ALC, Lima TP, Ferreira FD, Oliveira TF de, Yonamine M, Takayama L, Pereira RMR, Negrão CE, Passarelli M, Rochitte CE, Alves MJ de NN. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users [Internet]. Atherosclerosis. 2019 ; 283 100-105.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2019.02.006
Vancouver
Souza FR de, Santos MR dos, Porello RA, Fonseca GWP da, Sayegh ALC, Lima TP, Ferreira FD, Oliveira TF de, Yonamine M, Takayama L, Pereira RMR, Negrão CE, Passarelli M, Rochitte CE, Alves MJ de NN. Diminished cholesterol efflux mediated by HDL and coronary artery disease in young male anabolic androgenic steroid users [Internet]. Atherosclerosis. 2019 ; 283 100-105.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2019.02.006
Artigo de periodico
Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia (2019)
Isla, Leopoldo Perez de; Ray, Kausik K.; Watts, Gerald F.; Santos Filho, Raul Dias dos ; Alonso, Rodrigo; Muniz-grijalvo, Ovidio; Diaz-diaz, Jose Luis; Badimon, Lina; Catapano, Alberico L; Mata, Pedro
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, AVALIAÇÃO DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ISLA, Leopoldo Perez de; RAY, Kausik K.; WATTS, Gerald F.; et al. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, Clare, v. 286, p. 40-45, 2019. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/33058 > DOI: 10.1016/j.atherosclerosis.2019.05.003.
APA
Isla, L. P. de, Ray, K. K., Watts, G. F., Santos Filho, R. D. dos, Alonso, R., Muniz-grijalvo, O., et al. (2019). Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia. Atherosclerosis, 286, 40-45. doi:10.1016/j.atherosclerosis.2019.05.003
NLM
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.Available from: http://observatorio.fm.usp.br/handle/OPI/33058
Vancouver
Isla LP de, Ray KK, Watts GF, Santos Filho RD dos, Alonso R, Muniz-grijalvo O, Diaz-diaz JL, Badimon L, Catapano AL, Mata P. Potential utility of the SAFEHEART risk equation for rationalising the use of PCSK9 monoclonal antibodies in adults with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 286 40-45.Available from: http://observatorio.fm.usp.br/handle/OPI/33058
Artigo de periodico-carta/editorial
Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH (2019)
Santos Filho, Raul Dias dos; Watts, Gerald F
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, ARTERIOSCLEROSE, CORONARIOPATIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos; WATTS, Gerald F. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH. Atherosclerosis[S.l: s.n.], 2019.Disponível em: DOI: 10.1016/j.atherosclerosis.2018.12.013.
APA
Santos Filho, R. D. dos, & Watts, G. F. (2019). Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH. Atherosclerosis. Clare. doi:10.1016/j.atherosclerosis.2018.12.013
NLM
Santos Filho RD dos, Watts GF. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH [Internet]. Atherosclerosis. 2019 ; 281 145-147.Available from: http://observatorio.fm.usp.br/handle/OPI/31136
Vancouver
Santos Filho RD dos, Watts GF. Simon Broome confirms that the IAS definition of severe familial hypercholesterolemia predicts coronary mortality in patients with FH [Internet]. Atherosclerosis. 2019 ; 281 145-147.Available from: http://observatorio.fm.usp.br/handle/OPI/31136
Artigo de periodico
Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults (2018)
Fernandes, Romulo Araujo; Santos, Raul D
Source: Atherosclerosis. Unidade: FM
Subjects: ESTUDOS LONGITUDINAIS, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES, ÍNDICE DE MASSA CORPORAL, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Romulo Araujo; SANTOS, Raul D. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults. Atherosclerosis, Clare, v. 273, p. 131-135, 2018. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2018.02.011 > DOI: 10.1016/j.atherosclerosis.2018.02.011.
APA
Fernandes, R. A., & Santos, R. D. (2018). Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults. Atherosclerosis, 273, 131-135. doi:10.1016/j.atherosclerosis.2018.02.011
NLM
Fernandes RA, Santos RD. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults [Internet]. Atherosclerosis. 2018 ; 273 131-135.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2018.02.011
Vancouver
Fernandes RA, Santos RD. Self-initiated physical activity is associated with high sensitivity C-reactive protein: A longitudinal study in 5,030 adults [Internet]. Atherosclerosis. 2018 ; 273 131-135.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2018.02.011
Trabalho de evento-resumo periodico
Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: APNEIA DO SONO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira; TAVONI, Thauany Martins; SILVA, Vanessa Martins da; et al. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis[S.l: s.n.], 2018.Disponível em: .
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Chylomicron metabolism is impaired in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.182.Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy (2018)
Sigal, Gilbert Alexandre; Tavoni, Thauany Martins; Freitas, Fatima Rodrigues de; Silva, Bruna Miranda de Oliveira; Brandão, Lenine Garcia; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: LIPÍDEOS, HIPOTIREOIDISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIGAL, Gilbert Alexandre; TAVONI, Thauany Martins; FREITAS, Fatima Rodrigues de; et al. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy. Atherosclerosis[S.l: s.n.], 2018.Disponível em: .
APA
Sigal, G. A., Tavoni, T. M., Freitas, F. R. de, Silva, B. M. de O., Brandão, L. G., & Maranhão, R. C. (2018). Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy. Atherosclerosis. Clare. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Sigal GA, Tavoni TM, Freitas FR de, Silva BM de O, Brandão LG, Maranhão RC. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy [Internet]. Atherosclerosis. 2018 ; 275 e167 res. P2.5.217.Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Sigal GA, Tavoni TM, Freitas FR de, Silva BM de O, Brandão LG, Maranhão RC. Lipid transfers to HDL are diminished in women with overt hypothyroidism after total thyroidectomy [Internet]. Atherosclerosis. 2018 ; 275 e167 res. P2.5.217.Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions (2018)
Tavoni, Thauany Martins; Vinagre, Carmen Guilherme Christiano de Matos; Freitas, Fatima Rodrigues; Mesquita, Carlos Henrique de; Vinagre, Juliana Christiano de Matos; Mariani, A. C; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: Congress of the European Atherosclerosis Society/EAS. Unidades: FM, FCF
Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVONI, Thauany Martins; VINAGRE, Carmen Guilherme Christiano de Matos; FREITAS, Fatima Rodrigues; et al. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis[S.l: s.n.], 2018.Disponível em: .
APA
Tavoni, T. M., Vinagre, C. G. C. de M., Freitas, F. R., Mesquita, C. H. de, Vinagre, J. C. de M., Mariani, A. C., et al. (2018). Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions. Atherosclerosis. Clare. Recuperado de https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
NLM
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Vancouver
Tavoni TM, Vinagre CGC de M, Freitas FR, Mesquita CH de, Vinagre JC de M, Mariani AC, Kalil Filho R, Maranhão RC. Plasma clearance of chylomicron remnants is delayed in aged subjects: a study with artificial emulsions [Internet]. Atherosclerosis. 2018 ; 275 e157 res. P2.2.181.Available from: https://eas2018.com/wp-content/uploads/2018/05/EAS2018-programme.pdf
Trabalho de evento-resumo periodico
Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model (2018)
Meneghini, Bianca Correa; Tavares, Elaine Rufo; Guido, Maria Carolina; Tavoni, Thauany Martins; Kalil Filho, Roberto; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca Correa; TAVARES, Elaine Rufo; GUIDO, Maria Carolina; et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis[S.l: s.n.], 2018.Disponível em: .
APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Kalil Filho, R., & Maranhão, R. C. (2018). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Atherosclerosis. Clare. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Kalil Filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Atherosclerosis. 2018 ; 32 112-113 res. P3.088.Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Artigo de periodico
Morphometric measurements of extracranial and intracranial atherosclerotic disease: a population-based autopsy study (2018)
Suemoto, Claudia Kimie; Grinberg, Lea Tenenholz; Leite, Renata E. P.; Ferretti-Rebustini, Renata Eloah de Lucena; Jacob-filho, Wilson; Yaffe, Kristine; Nitrini, Ricardo; Pasqualucci, Carlos Augusto Gonçalves
Source: Atherosclerosis. Unidades: FM, EE
Subjects: FATORES DE RISCO, ARTERIOSCLEROSE, ARTÉRIAS CEREBRAIS, AUTÓPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUEMOTO, Claudia Kimie; GRINBERG, Lea Tenenholz; LEITE, Renata E. P.; et al. Morphometric measurements of extracranial and intracranial atherosclerotic disease: a population-based autopsy study. Atherosclerosis, Clare, v. 270, p. 218-223, 2018. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2017.12.015 > DOI: 10.1016/j.atherosclerosis.2017.12.015.
APA
Suemoto, C. K., Grinberg, L. T., Leite, R. E. P., Ferretti-Rebustini, R. E. de L., Jacob-filho, W., Yaffe, K., et al. (2018). Morphometric measurements of extracranial and intracranial atherosclerotic disease: a population-based autopsy study. Atherosclerosis, 270, 218-223. doi:10.1016/j.atherosclerosis.2017.12.015
NLM
Suemoto CK, Grinberg LT, Leite REP, Ferretti-Rebustini RE de L, Jacob-filho W, Yaffe K, Nitrini R, Pasqualucci CAG. Morphometric measurements of extracranial and intracranial atherosclerotic disease: a population-based autopsy study [Internet]. Atherosclerosis. 2018 ; 270 218-223.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2017.12.015
Vancouver
Suemoto CK, Grinberg LT, Leite REP, Ferretti-Rebustini RE de L, Jacob-filho W, Yaffe K, Nitrini R, Pasqualucci CAG. Morphometric measurements of extracranial and intracranial atherosclerotic disease: a population-based autopsy study [Internet]. Atherosclerosis. 2018 ; 270 218-223.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2017.12.015
Trabalho de evento-resumo periodico
Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure (2018)
Drager, Luciano Ferreira; Tavoni, Thauany Martins; Silva, Vanessa Martins da; Santos, Raul Dias dos; Pedrosa, Rodrigo Pinto; Bortolotto, Luiz Aparecido; Vinagre, Carmen Guilherme Christiano de Matos; Polotsky, Vsevolod Y; Lorenzi Filho, Geraldo; Maranhão, Raul Cavalcante
Source: Atherosclerosis. Conference titles: International Symposium on Atherosclerosis/ISA. Unidades: FM, FCF
Subjects: APNEIA DO SONO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DRAGER, Luciano Ferreira; TAVONI, Thauany Martins; SILVA, Vanessa Martins da; et al. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis[S.l: s.n.], 2018.Disponível em: .
APA
Drager, L. F., Tavoni, T. M., Silva, V. M. da, Santos, R. D. dos, Pedrosa, R. P., Bortolotto, L. A., et al. (2018). Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Atherosclerosis. Clare. Recuperado de https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
NLM
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Vancouver
Drager LF, Tavoni TM, Silva VM da, Santos RD dos, Pedrosa RP, Bortolotto LA, Vinagre CGC de M, Polotsky VY, Lorenzi Filho G, Maranhão RC. Plasma kinetics of chylomicron in patients with obstructive sleep apnea: effects of treatment with continuous positive airway pressure [Internet]. Atherosclerosis. 2018 ; 32 63-64 res. P1.099.Available from: https://www.atherosclerosis-supplements.com/article/S1567-5688(18)30192-2/pdf
Artigo de periodico
Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice (2018)
Pang, Jing; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, DIAGNÓSTICO PRECOCE, ACONSELHAMENTO, MODO DE VIDA, SUL-AFRICANOS, AUSTRALIANOS, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PANG, Jing; SANTOS FILHO, Raul Dias dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice. Atherosclerosis, Clare, v. 277, p. 470-476, 2018. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.822 > DOI: 10.1016/j.atherosclerosis.2018.06.822.
APA
Pang, J., & Santos Filho, R. D. dos. (2018). Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice. Atherosclerosis, 277, 470-476. doi:10.1016/j.atherosclerosis.2018.06.822
NLM
Pang J, Santos Filho RD dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice [Internet]. Atherosclerosis. 2018 ; 277 470-476.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.822
Vancouver
Pang J, Santos Filho RD dos. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: importance of early detection and lifestyle advice [Internet]. Atherosclerosis. 2018 ; 277 470-476.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2018.06.822
Artigo de periodico
Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil (2018)
Souto, Ana Cristina; Krieger, José Eduardo; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, QUALIDADE DE VIDA, TRIAGEM, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA, BRASILEIROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUTO, Ana Cristina; KRIEGER, José Eduardo; SANTOS FILHO, Raul Dias dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Atherosclerosis, Clare, v. 277, p. 464-469, 2018. Disponível em: < http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.036 > DOI: 10.1016/j.atherosclerosis.2018.05.036.
APA
Souto, A. C., Krieger, J. E., & Santos Filho, R. D. dos. (2018). Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Atherosclerosis, 277, 464-469. doi:10.1016/j.atherosclerosis.2018.05.036
NLM
Souto AC, Krieger JE, Santos Filho RD dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil [Internet]. Atherosclerosis. 2018 ; 277 464-469.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.036
Vancouver
Souto AC, Krieger JE, Santos Filho RD dos. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil [Internet]. Atherosclerosis. 2018 ; 277 464-469.Available from: http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.036

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Countries/Territories

Funding Agencies

Normalized affiliation

Non normalized affiliation

Keywords